Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock

Intensive Care Medicine

Volumn 37, Issue 8, 2011, Pages 1344-1351

  Aboab, Jerome ^a   Sebille, Veronique ^b   Jourdain, Mercé ^c   Mangalaboyi, Jacques ^c   Gharbi, Miloud ^a   Mansart, Arnaud ^a   Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Animal model; Beta blockade; Esmolol; Hemodynamics; Septic shock

Indexed keywords

ENDOTOXIN; ESMOLOL; ISOTONIC SOLUTION; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR FUNCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HEART INDEX; HEART OUTPUT; HEART RATE; NONHUMAN; OXYGENATION; PROSPECTIVE STUDY; SEPTIC SHOCK; SWINE; SYSTEMIC VASCULAR RESISTANCE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; INFUSIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MONITORING, PHYSIOLOGIC; PROPANOLAMINES; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SWINE;

EID: 79961027258     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2236-y     Document Type: Article

References (30)

1. D Annane E Bellissant JM Cavaillon 2005 Septic shock Lancet 365 63 78 15639681 10.1016/S0140-6736(04)17667-8 1:CAS:528:DC%2BD2MXhvF2gsA%3D%3D (Pubitemid 40082148)
2. JE Parrillo MM Parker C Natanson AF Suffredini RL Danner RE Cunnion FP Ognibene 1990 Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy Ann Intern Med 113 227 242 2197912 1:STN:280:DyaK3czivVGntg%3D%3D (Pubitemid 20242299)
3. T Gulick MK Chung SJ Pieper 1989 Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness Proc Natl Acad Sci USA 86 6753 6757 2549546 10.1073/pnas.86.17.6753 1:CAS:528:DyaL1MXlsFWkurY%3D (Pubitemid 19236340)
4. A Kumar V Thota L Dee J Olson E Uretz JE Parrillo 1996 Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum J Exp Med 183 949 958 8642298 10.1084/jem.183.3.949 1:CAS:528:DyaK28XhvV2qsr0%3D (Pubitemid 26113964)
5. CR Benedict DG Grahame-Smith 1978 Plasma noradrenaline and adrenaline concentrations and dopamine beta hydroxylase activity in patients with shock due to septicemia, trauma, and heamorrhage Q J Med 185 1 20 (Pubitemid 8282716)
6. B Goldstein MH Kempski D Stair RB Tipton D De King DJ De Long R De Asla C Cox N Lund PD Woolf 1995 Autonomic modulation of heart rate variability during endotoxin shock in rabbits Crit Care Med 23 1694 1702 7587235 10.1097/00003246-199510000-00014 1:STN:280:DyaK28%2FhvFyruw%3D%3D
7. D Annane F Trabold T Sharshar I Jarrin AS Blanc JC Raphael P Gajdos 1999 Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach Am J Respir Crit Care Med 160 458 465 10430714 1:STN:280:DyaK1MzlvFKrsQ%3D%3D (Pubitemid 29380658)
8. DL Mann MR Bristow 2005 Mechanisms and models in heart failure: the biomechanical model and beyond Circulation 11 2837 2849 10.1161/CIRCULATIONAHA. 104.500546 (Pubitemid 40791557)
9. T Sharshar F Gray G Lorin de la Grandmaison NS Hopkinson E Ross A Dorandeu D Orlikowski JC Raphael P Gajdos D Annane 2003 Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock Lancet 362 1799 1805 14654318 10.1016/S0140- 6736(03)14899-4 1:CAS:528:DC%2BD3sXptlOiuro%3D (Pubitemid 37494758)
10. MR Bristow AM Feldman KF Adams Jr S Goldstein 2003 Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? J Card Fail 9 444 453 14966783 10.1016/j.cardfail.2003.10.009 1:CAS:528:DC%2BD3sXhtVShs77E (Pubitemid 38055651)
11. E de Montmollin J Aboab A Mansart D Annane 2009 Bench-to-bedside review: beta-adrenergic modulation in sepsis Crit Care 13 230 19863760 10.1186/cc8026
12. K Werdan H Schmidt H Ebelt K Zorn-Pauly B Koidl RS Hoke K Heinroth U Müller-Werdan 2009 Impaired regulation of cardiac function in sepsis, SIRS, MODS Can J Physiol Pharmacol 87 266 274 19370080 10.1139/Y09-012 1:CAS:528:DC%2BD1MXksVyit7s%3D
13. M Zaugg MC Schaub T Pasch 2002 Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br J Anaesth 88 101 123 11881864 10.1093/bja/88.1.101 1:CAS:528: DC%2BD38XntFaksw%3D%3D (Pubitemid 34048569)
14. DT Mangano EL Layug A Wallace I Tateo 1996 Effect of atenolol on mortality and cardiovascular morbidity after non cardiac surgery N Engl J Med 335 1713 1720 8929262 10.1056/NEJM199612053352301 1:CAS:528:DyaK2sXls1Og (Pubitemid 26399345)
15. D Poldermans E Boersma JJ Bax 1999 The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery N Engl J Med 341 1789 1794 10588963 10.1056/NEJM199912093412402 1:CAS:528:DC%2BD3cXhsVektA%3D%3D
16. DN Herndon DW Hart SE Wolf DL Chinkes RR Wolfe 2001 Reversal of catabolism by beta-blockade after severe burns N Engl J Med 345 1223 1229 11680441 10.1056/NEJMoa010342 1:CAS:528:DC%2BD3MXnslOnsLg%3D (Pubitemid 34951485)
17. DC Gore RR Wolfe 2006 Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis Surgery 139 686 694 16701103 10.1016/j.surg.2005.10.010
18. T Suzuki H Morisaki R Serita M Yamamoto Y Kotate A Ishizaka J Takeda 2005 Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats Crit Care Med 33 2294 2301 16215384 10.1097/01.CCM.0000182796.11329.3B 1:CAS:528:DC%2BD2MXhtVymt7fM (Pubitemid 41437484)
19. GL Ackland ST Yao A Rudiger A Dyson R Stidwill D Poputnikov M Singer AV Gourine 2010 Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats Crit Care Med 38 388 394 19829100 10.1097/CCM.0b013e3181c03dfa 1:CAS:528:DC%2BC3cXpsVShsg%3D%3D
20. M Jourdain O Carrette A Tournoys F Fourrier C Mizon J Mangalaboyi J Goudemand J Mizon C Chopin 1997 Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation Am J Respir Crit Care Med 156 1825 1833 9412562 1:STN:280:DyaK1c%2FnsVSgug%3D%3D (Pubitemid 28011789)
21. R Fincke JS Hochman AM Lowe V Menon JN Slater JG Webb TH Le Jemtel G Cotter Shock Investigators 2004 Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the shock trial registry J Am Coll Cardiol 44 340 348 15261929 10.1016/j.jacc.2004.03.060 (Pubitemid 38950593)
22. KW Kelley SE Curtis GT Marzan HM Karara CR Anderson 1973 Body surface area of female swine J Anim Sci 36 927 930 4703721 1:STN:280: DyaE3s7nsFeksg%3D%3D
23. Verbeke G, Molenberghs G (2000) Linear mixed models for longitudinal data. Springer, New York
24. MG Kenward JH Roger 1997 Small sample inference for fixed effects from restricted maximum likelihood Biometrics 53 983 997 9333350 10.2307/2533558 1:STN:280:DyaK2svntVGitw%3D%3D (Pubitemid 27391027)
25. H Akaike 1974 A new look at the statistical model identification IEEE Trans Automat Control AC-19 716 723 10.1109/TAC.1974.1100705
26. G Schwarz 1978 Estimating the dimension of a model Ann Stat 6 461 464 10.1214/aos/1176344136
27. Schmidt DA, Tumbleson ME (1986) Swine hematology. In: Tumbleson ME (ed) Swine in biomedical research. Plenum, New York, pp 767-782
28. C Volz-Zang B Eckrich P Jahn B Schneidrowski B Schulte D Palm 1994 Esmolol, an ultrashort acting selective beta 1-adrenoreceptor antagonist: pharmacodynamic and pharmacokinetic properties Eur J Clin Pharmacol 46 399 404 7957532 10.1007/BF00191900 1:CAS:528:DyaK2cXmsVGltL0%3D
29. JL Berk JF Hagen WH Beyer MJ Gerber GR Dochat 1969 The treatment of endotoxin shock by beta adrenergic blockade Ann Surg 169 74 81 4883485 10.1097/00000658-196901000-00007 1:CAS:528:DyaF1MXms1GnsA%3D%3D
30. POISE Study Group PJ Devereaux H Yang S Yusuf G Guyatt K Leslie JC Villar D Xavier S Chrolavicius L Greenspan J Pogue P Pais L Liu S Xu G Málaga A Avezum M Chan VM Montori M Jacka P Choi 2008 Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 1839 1847 18479744 10.1016/S0140- 6736(08)60601-7 1:CAS:528:DC%2BD1cXmsFKnsbc%3D